Moreover, ISL hampers breast cancer growth and the neoangiogenesis accompanying suppressed VEGF/VEGFR-2 signaling, which prompts HIF-1α proteasome degradation or directly blocks VEGF-2 (Figure 3) [39]. This evidence concerns the gene VEGFA and breast carcinoma.